T90S (p.Thr90Ser) variant of NFKBIA (NF-kappa-B inhibitor alpha)

T90S (p.Thr90Ser) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Inborn genetic diseases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.34 / 1. The record also includes population frequency data and structural context.

T90S (p.Thr90Ser) variant details